G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $634,678 | -40.9% | 440,633 | +2.1% | 0.00% | – |
| Q2 2023 | $1,074,813 | -8.5% | 431,652 | -1.5% | 0.00% | – |
| Q1 2023 | $1,174,895 | +60933.5% | 438,394 | +23.7% | 0.00% | – |
| Q4 2022 | $1,925 | -100.0% | 354,539 | +2.1% | 0.00% | -100.0% |
| Q3 2022 | $4,337,000 | +156.9% | 347,255 | +1.6% | 0.00% | – |
| Q2 2022 | $1,688,000 | -66.8% | 341,895 | -48.8% | 0.00% | -100.0% |
| Q1 2022 | $5,077,000 | -30.5% | 668,140 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $7,303,000 | -15.4% | 715,373 | +11.2% | 0.00% | 0.0% |
| Q3 2021 | $8,630,000 | -35.5% | 643,103 | +5.4% | 0.00% | -50.0% |
| Q2 2021 | $13,390,000 | +1.0% | 610,324 | +10.7% | 0.00% | 0.0% |
| Q1 2021 | $13,261,000 | +52.4% | 551,183 | +13.9% | 0.00% | +100.0% |
| Q4 2020 | $8,704,000 | +61.7% | 483,840 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $5,383,000 | -52.6% | 466,128 | -0.4% | 0.00% | -50.0% |
| Q2 2020 | $11,351,000 | +125.0% | 467,921 | +2.2% | 0.00% | +100.0% |
| Q1 2020 | $5,045,000 | -77.0% | 457,835 | -44.9% | 0.00% | -50.0% |
| Q4 2019 | $21,974,000 | +140.7% | 831,410 | +107.5% | 0.00% | 0.0% |
| Q3 2019 | $9,128,000 | -21.8% | 400,716 | +5.3% | 0.00% | -33.3% |
| Q2 2019 | $11,669,000 | +125.1% | 380,600 | +21.9% | 0.00% | +200.0% |
| Q1 2019 | $5,183,000 | -51.5% | 312,230 | -44.1% | 0.00% | -50.0% |
| Q4 2018 | $10,688,000 | -19.2% | 558,126 | +120.6% | 0.00% | -50.0% |
| Q3 2018 | $13,227,000 | +38.7% | 252,965 | +15.3% | 0.00% | +33.3% |
| Q2 2018 | $9,535,000 | +38.4% | 219,411 | +18.0% | 0.00% | +50.0% |
| Q1 2018 | $6,890,000 | +268.1% | 185,977 | +97.1% | 0.00% | +100.0% |
| Q4 2017 | $1,872,000 | -12.8% | 94,366 | +9.3% | 0.00% | 0.0% |
| Q3 2017 | $2,148,000 | +1106.7% | 86,305 | +744.5% | 0.00% | – |
| Q2 2017 | $178,000 | – | 10,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |